Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2124 of 6351
-
Exercise program aims to steady the steps of Parkinson's patients
Disease control CompletedThe primary objective of this study is to investigate the effects of a theoretically driven, highly challenging exercise program (balance and strengthening exercises) in reducing fall rate, improving balance and reducing fear of falling in persons with Parkinson's disease. In th…
Sponsor: Boston University Charles River Campus • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Can a drug combo overcome resistance in multiple myeloma?
Disease control CompletedPhase IIb clinical trial to determine if resistance to a lenalidomide containing regimen can be overcome by the addition of vorinostat, in patients with relapsed and refractory multiple myeloma.
Phase 1/2 • Sponsor: Hackensack Meridian Health • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Spinal cord injury patients may regain seated control with implanted device
Disease control Recruiting nowThe purpose of this study is to evaluate a surgically implanted functional electrical stimulation (FES) system to facilitate stability of the trunk and hips. FES involves applying small electric currents to the nerves, which cause the muscles to contract. This study evaluates how…
Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Shorter antibiotic course could spare joint infection patients weeks of treatment
Disease control CompletedThe study is a prospective, open randomized, non-inferiority trial with two parallel groups, comparing 6 weeks versus 12 weeks of antibiotic treatment following surgery procedure (debridement and retention, 1-stage or 2 stage exchange). The duration of the treatment antibiotic o…
Phase 3 • Sponsor: University Hospital, Tours • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Can a seizure drug help you quit drinking and smoking?
Disease control CompletedThis research study aims to test whether topiramate (a drug that is being used for seizure) will help individuals who have problems with both alcohol and nicotine. The investigators believe that individuals taking topiramate will be more successful at abstaining from both alcohol…
Phase 2/3 • Sponsor: University of Virginia • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New combo therapy shows promise for Hard-to-Treat head and neck cancer
Disease control OngoingThis phase I/II trial studies the side effects and best dose of recombinant interleukin-12 when given together with cetuximab and to see how well they work in treating patients with squamous cell carcinoma of the head and neck that has come back, spread to another place in the bo…
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Thin air, thicker blood? hypoxia training may supercharge red blood cell production — at a cost
Knowledge-focused CompletedThis study investigates how training under conditions of reduced oxygen (intermittent hypoxia) affects the body's ability to produce red blood cells and manage iron levels, compared to training under normal oxygen conditions. Red blood cells are essential for transporting oxygen …
Sponsor: Néstor Vicente-Salar • Aim: Knowledge-focused
Last updated Jul 24, 2026 00:00 UTC
-
Steroid shot may buy time for men with tough prostate cancer
Disease control CompletedWhen metastatic prostate cancer becomes unresponsive to hormone therapy, it is known as castration resistant prostate cancer, treatment options are limited and response to this treatment can be short. The standard treatment for this type of cancer (hydrocortisone or dexamethason…
Phase 2 • Sponsor: Barts & The London NHS Trust • Aim: Disease control
Last updated Jun 26, 2026 14:49 UTC
-
Frailty test could predict who survives liver transplant waiting list
Knowledge-focused Recruiting nowThis will be a prospective cohort study of patients with liver disease. Subjects will undergo geriatric assessments of frailty, functional status, and disability using functional status measures at baseline and at every clinic visit in the pre-transplant setting. Subjects will al…
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Jul 16, 2026 00:00 UTC
-
Tailored workouts may keep elderly cancer patients on their feet
Disease control CompletedThe investigators will propose to older cancer patients with good prognosis (curative care) a randomized trial of adapted physical activity during one year. To increase generalisation of the intervention the investigators intend to compare the PNNS advices (the French National Nu…
Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New combo therapy may help newly diagnosed diabetics go Drug-Free for a year
Disease control CompletedThe purpose of this study is to investigate and evaluate the effects of different oral antihyperglycaemic agents combined with short-term continuous subcutaneous insulin infusion(CSII)(1.CSII alone; 2.metformin and pioglitazone combined with CSII; 3. sitagliptin combined with CSI…
Phase 4 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Lung cancer gene test without surgery shows promise
Knowledge-focused Recruiting nowLung cancer is the leading cause of death in the world. Overall 5-year survival rate is fewer than 10% and the effectiveness of conventional chemotherapy is limited. The new knowledge shows the correlation between genetic alteration and effective of chemotherapy. Therefore non-su…
Sponsor: University Health Network, Toronto • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Could a pacemaker for the vagus nerve tame heart failure?
Disease control OngoingThe NECTAR-HF feasibility trial is designed to evaluate the application of right vagal nerve stimulation in heart failure patients with a New York Heart Association Class III, an ejection fraction equal to or less than 35 %, and a narrow QRS duration equal to or less than 130 ms.
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
One-Time radiation during surgery shows promise in breast cancer control
Disease control CompletedQuality Control Registry for IORT used as an anticipiated boost with 20 Gy at the applicator surface followed by EBRT
Sponsor: Universitätsmedizin Mannheim • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Brain stimulation shows promise for unexplained paralysis
Symptom relief CompletedPsychogenic paralysis presents a real treatment challenge. Despite psychotherapy, physiotherapy, antidepressants, acupuncture or hypnosis, the outcome is not always satisfactory with persistent symptoms after long-term follow-up. In a preliminary retrospective study on 70 patient…
Sponsor: University Hospital, Rouen • Aim: Symptom relief
Last updated Jun 27, 2026 12:10 UTC
-
Engineered immune cells take aim at returning blood cancers
Disease control OngoingThe purpose of this study is to test the safety of giving the patient special cells from a donor called "Modified T-cells". The goal is to assess the toxicities of T-cells for patients with relapsed B cell leukemia or lymphoma after a blood SCT organ SCT or for patients who are a…
Phase 1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:08 UTC
-
Weekly antibiotic rotation could slash UTIs in neurogenic bladder patients
Prevention CompletedSymptomatic urinary tract infections (UTIs) are one of the main causes of morbidity and the main cause of re-hospitalization in subjects with neurogenic bladder. Long-term antibiotic therapy increases the risk of multi-resistant bacterial infections, without reducing the rate of …
Phase 4 • Sponsor: University Hospital, Tours • Aim: Prevention
Last updated Jun 27, 2026 08:06 UTC
-
Gene therapy cocktail takes aim at Hard-to-Treat melanoma
Disease control CompletedThis research study involves two investigational drugs, an Activator Ligand (INXN-1001) in combination with an Adenovirus Vector Engineered to Express hIL-12 (INXN-2001). IL-12 is a protein that may improve the body's natural response to disease by enhancing the ability of the im…
Phase 1/2 • Sponsor: Alaunos Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Should symptom-free patients get early heart valve repair? new trial investigates.
Disease control OngoingAlthough percutaneous mitral commissurotomy (PMC) has been accepted as an effective treatment for symptomatic patients with moderate or severe mitral stenosis (MS), most asymptomatic patients are not candidates for PMC owing to the small but inherent procedure-related risks. Asym…
Sponsor: Asan Medical Center • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New drug combo aims to save bladders in cancer fight
Disease control Stopped earlyIf radical cystectomy remains the standard of care for muscle invasive bladder cancer, consequences of this surgical procedure are often harsh. Over the past years, concurrent chemo-radiotherapy has imposed itself as an alternative treatment. Published data on concomitant radioch…
Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC